BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20939855)

  • 21. Heterogeneity of lower esophageal sphincter function in children with achalasia.
    Morera C; Nurko S
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):34-40. PubMed ID: 21694632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achalasia with complete relaxation of lower esophageal sphincter: radiographic-manometric correlation.
    Amaravadi R; Levine MS; Rubesin SE; Laufer I; Redfern RO; Katzka DA
    Radiology; 2005 Jun; 235(3):886-91. PubMed ID: 15833990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intrasphincteric injection of botulinum toxin in patients with esophageal achalasia].
    Zapata R; Carvajal S; Alvarez M; González R; Chianale J; Rollán A
    Rev Med Chil; 1997 Aug; 125(8):899-904. PubMed ID: 9567393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between bolus transit and LES-relaxation studied with concurrent impedance and manometry.
    Nguyen HN; Domingues GR; Winograd R; Lammert F; Silny J; Matern S
    Hepatogastroenterology; 2006; 53(68):218-23. PubMed ID: 16608028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achalasia in a patient with adult-onset Tay-Sachs disease.
    Nathanson JW; Winans CS
    Dig Dis Sci; 2006 Jan; 51(1):132-7. PubMed ID: 16416225
    [No Abstract]   [Full Text] [Related]  

  • 26. Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy.
    Restivo DA; Marchese-Ragona R; Lauria G; Squatrito S; Gullo D; Vigneri R
    Diabetes Care; 2006 Dec; 29(12):2650-3. PubMed ID: 17130199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments in esophageal motor disorders.
    Nguyen NQ; Holloway RH
    Curr Opin Gastroenterol; 2005 Jul; 21(4):478-84. PubMed ID: 15930992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term results of laparoscopic partial posterior fundoplication in patients with esophageal reflux and disorders of esophageal peristalsis].
    Gadenstätter M; Klingler A; Klocker H; Wetscher GJ
    Wien Klin Wochenschr; 2000 Jan; 112(2):70-4. PubMed ID: 10703154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoration of peristalsis in the esophagus of a patient diagnosed of achalasia.
    Ciriza de los Ríos C; García L; Díez A; Pérez de la Serna J; Romero MJ; Dajil S; Ruiz de León A
    Rev Esp Enferm Dig; 2002 Nov; 94(11):697-702. PubMed ID: 12690993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction.
    Kelly EA; Koszewski IJ; Jaradeh SS; Merati AL; Blumin JH; Bock JM
    Ann Otol Rhinol Laryngol; 2013 Feb; 122(2):100-8. PubMed ID: 23534124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin for the treatment of upper gastrointestinal diseases: the future or already the past?
    Madaliński MH
    Endoscopy; 2003 Apr; 35(4):366-7; author reply 368-9. PubMed ID: 12664398
    [No Abstract]   [Full Text] [Related]  

  • 32. Lower esophageal sphincter relaxation characteristics using a sleeve sensor in clinical manometry.
    Shi G; Ergun GA; Manka M; Kahrilas PJ
    Am J Gastroenterol; 1998 Dec; 93(12):2373-9. PubMed ID: 9860395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of achalasia patients treated with botulinum toxin.
    D'Onofrio V; Miletto P; Leandro G; Iaquinto G
    Dig Liver Dis; 2002 Feb; 34(2):105-10. PubMed ID: 11926552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esophageal manometry: a comparison of findings in younger and older patients.
    Ribeiro AC; Klingler PJ; Hinder RA; DeVault K
    Am J Gastroenterol; 1998 May; 93(5):706-10. PubMed ID: 9625113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC; DelGaudio JM; Hapner ER; Johns MM
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrasphincteric botulinum toxin for the treatment of achalasia.
    Pasricha PJ; Ravich WJ; Hendrix TR; Sostre S; Jones B; Kalloo AN
    N Engl J Med; 1995 Mar; 332(12):774-8. PubMed ID: 7862180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction.
    Wehrmann T; Seifert H; Seipp M; Lembcke B; Caspary WF
    Endoscopy; 1998 Oct; 30(8):702-7. PubMed ID: 9865560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pneumatic dilation and myotomy on esophageal function and morphology in patients with achalasia.
    Gockel I; Junginger T; Eckardt VF
    Am Surg; 2005 Feb; 71(2):128-31. PubMed ID: 16022011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of esophageal inhibition during swallowing, pharyngeal stimulation, and transient LES relaxation. Lower esophageal sphincter.
    Pouderoux P; Verdier E; Kahrilas PJ
    Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G242-7. PubMed ID: 12388187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Botulinum toxin injection in the management of achalasia.
    Ramzan Z; Nassri AB
    Curr Opin Gastroenterol; 2013 Jul; 29(4):468-73. PubMed ID: 23695428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.